Busey Bank Has $22.66 Million Position in Danaher Co. (NYSE:DHR)

Busey Bank increased its position in shares of Danaher Co. (NYSE:DHR) by 2.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 98,698 shares of the conglomerate’s stock after purchasing an additional 2,254 shares during the quarter. Busey Bank’s holdings in Danaher were worth $22,656,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in DHR. FMR LLC increased its position in shares of Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Danaher by 3.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock valued at $1,417,342,000 after buying an additional 148,251 shares during the period. Fisher Asset Management LLC raised its stake in shares of Danaher by 2.6% in the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock valued at $1,265,725,000 after buying an additional 116,299 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after acquiring an additional 535,254 shares during the period. Finally, Montrusco Bolton Investments Inc. boosted its position in shares of Danaher by 0.6% during the 4th quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate’s stock valued at $382,936,000 after acquiring an additional 9,942 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR stock opened at $223.12 on Thursday. The firm has a market capitalization of $161.16 billion, a price-to-earnings ratio of 42.58, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. Danaher Co. has a 12-month low of $223.00 and a 12-month high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm has a fifty day moving average of $236.09 and a 200-day moving average of $253.66.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same quarter last year, the company earned $2.09 EPS. On average, equities research analysts forecast that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is presently 20.61%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on DHR shares. Citigroup dropped their price objective on Danaher from $305.00 to $285.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Jefferies Financial Group dropped their price target on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday. TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Raymond James cut their price target on Danaher from $300.00 to $275.00 and set an “outperform” rating for the company in a report on Tuesday, January 21st. Finally, Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $282.48.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.